- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Differential Diagnosis: Key Features of Demodex Blepharitis
Factors that differentiate Demodex blepharitis apart from other lid margin and ocular surface diseases with overlapping signs and symptoms are examined.
EP: 1.Overview of Demodex Blepharitis
EP: 2.Pathophysiology of Demodex Blepharitis
EP: 3.Diagnosing Demodex Blepharitis in Clinical Practice
EP: 4.Differential Diagnosis: Key Features of Demodex Blepharitis
EP: 5.Risk Factors and Mental Health Impact of Demodex Blepharitis
EP: 6.Treatment of Demodex Blepharitis
EP: 7.Diagnosis and Prevalence of Demodex Blepharitis
EP: 8.Exploring a Recently Approved Therapy for Demodex
EP: 9.Payer Approval + Alternate Treatments for Demodex Blepharitis
EP: 10.Outlook on the Future of Demodex Blepharitis Treatment
EP: 11.Understanding Demodex Blepharitis Pathogenesis
EP: 12.Cost-Effective Medication Access in Demodex Blepharitis Treatment
EP: 13.Other Clinical Considerations in Demodex Blepharitis Treatment
This is a video synopsis/summary of a discussion involving Elizabeth Yeu, MD.
Yeu discusses how Demodex blepharitis shares some nonspecific symptoms with other lid and ocular surface diseases, such as irritation, foreign body sensation, and watery eyes. However, patients with Demodex blepharitis uniquely have worse morning symptoms and itching or matting of the eyelids. She states that slit lamp exam showing pathognomonic debris extrusion can help distinguish Demodex blepharitis from lookalike conditions when paired with the characteristic symptoms. Citing data from the TITAN study of over 1000 patients at 7 US clinics and a separate 200-patient study by Eric Rosenberg, DO, MSE, Yeu notes a Demodex blepharitis prevalence of 50% to 58% among patients presenting to eye care offices. She emphasizes that the disease is common enough to warrant a high index of suspicion and deliberate diagnostic approach, differentiating it from similar inflammatory conditions.
Video synopsis is AI-generated and reviewed by AJMCÒ editorial staff.
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
November 21st 2024A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
